Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone for moderate to severe facial acne vulgaris in adult women
jRCTs041250218Recruiting
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of spironolactone in acne vulgaris (2 arms). Primary endpoint: Change from baseline in inflammatory lesion count at Week 12 on the face. Started Apr 2026; status: recruiting.
02
Drugs
spironolactone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on jRCTs041250218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041250218.